has a place in the effort to avert acute attacks; however, its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward ...
Your healthcare team can best advise you on treatment for COPD exacerbations. If you live with chronic obstructive pulmonary disease (COPD), you may experience shortness of breath, wheezing ...
Hosted on MSN2mon
Fasenra shows benefit in acute asthma and COPD in Phase II trialIt included 158 patients, randomly assigned treatment at the point of acute eosinophilic exacerbation of asthma or COPD. The study originally screened 287 patients for inclusion, but 129 were ...
Hosted on MSN1mon
Difference between acute and chronic asthma: Symptoms to watch out for, tips to manageAlthough asthma can be a serious condition, it can be managed with the right treatment.” Dr Anusha CM revealed, “It’s a condition where acute asthma ... and frequent exacerbations or worseni ...
Airsupra (PT027), a new asthma rescue treatment ... of severe exacerbations regardless of their disease severity or level of control. Current albuterol rescue inhalers alleviate acute symptoms ...
Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and ...
Ethris Presents Positive Topline Phase 1 Data with mRNA Lead Candidate ETH47 for Uncontrolled Asthma
“These positive Phase 1 results reinforce the promise of ETH47 as a potentially safe and transformative treatment ... Approximately 80% of acute asthma attacks (exacerbations) are associated ...
Ethris Presents Positive Topline Phase 1 Data with mRNA Lead Candidate ETH47 for Uncontrolled Asthma
MUNICH, Germany I January 30, 2025 I Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results